Evidence map›Paper›PMID 42075910›Full record

ArticleMolecules (Basel, Switzerland)2026

Design, Synthesis, and Biological Activity of Boron-Bearing Sugar Derivatives for Boron Neutron Capture Therapy (BNCT).

Mengyan Hou, Xia Li, Yan Li, Wenhao Shi, Haotian Tang, Fang Feng, Xuan Wan, Hua Xie, Guilong Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengyan HouSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Xia LiSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Yan LiShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.ORCID 0000-0001-6186-8514
Wenhao ShiZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
Haotian TangZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
Fang FengShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Xuan WanShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Hua XieSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Guilong ZhaoSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.ORCID 0000-0001-8170-2909

Funding

Creative Research Group of Zhongshan City (Lingnan Pharmaceutical Research and Innovation team) CXTD2022011Special Funds of National Natural Science Foundation of China 82441046Zhongshan Municipal Natural Science Foundation 2023B2019
6 · The paper itself

Abstract

Radiotherapy is one of the conventional methods for the treatment of cancers. Boron neutron capture therapy (BNCT) has emerged as a promising and well-recognized modality for treating certain types of cancers. BNCT is a binary radiotherapy that largely depends on neutron beams and

Indexed as

BoronBoron CompoundsBoron Neutron Capture TherapySugarsCell Line, TumorGlucose Transporter Type 1HumansBoronBoron CompoundsGlucose Transporter Type 1SugarsBNCTboron neutron capture therapycarbohydrateGLUT1sugar

Identifiers

PMID42075910
PMCPMC13118604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.